Clinical differences between men and women with psoriatic arthritis: Relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Queiro, Rubén ^a   Tejón, Patricia ^a   Coto, Pablo ^a   Alonso, Sara ^a   Alperi, Mercedes ^a   Sarasqueta, Cristina ^b   González, Segundo ^c   Martínez Borra, Jesús ^d   López Larrea, Carlos ^d   Ballina, Javier ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

^d HUCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; HLA DR17 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; MHC CLASS I-RELATED CHAIN A; MHC CLASS I RELATED CHAIN A;

ADULT; ARTHRITIS; ARTICLE; DACTYLITIS; DNA POLYMORPHISM; ENTHESITIS; FAMILY HISTORY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HLA TYPING; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; NAIL DISEASE; ONSET AGE; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SEX DIFFERENCE; ARTHRITIS, PSORIATIC; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; JOINT; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SPAIN;

ADULT; AGE OF ONSET; ARTHRITIS, PSORIATIC; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; JOINTS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPAIN;

EID: 84877312245     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/482691     Document Type: Article

References (25)

1. Castelino M., Barton A., Genetic susceptibility factors for psoriatic arthritis. Current Opinion in Rheumatology 2010 22 2 152 156 10.1097/BOR.0b013e32833669d2
2. Martínez-Borra J., Brautbar C., González S., Enk C. D., López-Vázquez A., López-Larrea C., The region of 150 kb telometic to HLA-C is associated with psoriasis in the Jewish population. Journal of Investigative Dermatology 2005 125 5 928 932
3. Martínez-Borra J., González S., Santos-Juanes J., Sánchez del Rio J., Torre-Alonso J. C., López-Vazquez A., Blanco-Geláz M. A., López-Larrea C., Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology 2003 42 9 1089 1092 10.1093/rheumatology/keg304 (Pubitemid 37220999)
4. Gladman D. D., Antoni C., Mease P., Clegg D. O., Nash O., Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Annals of the Rheumatic Diseases 2005 64 2 ii14 ii17 2-s2.0-14244260176 10.1136/ard.2004. 032482 (Pubitemid 40288513)
5. Alenius G. M., Stenberg B., Stenlund H., Lundblad M., Dahlqvist S. R., Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. Journal of Rheumatology 2002 29 12 2577 2582 2-s2.0-0036897435 (Pubitemid 35416965)
6. Gonzalez S., Martinez-Borra J., Torre-Alonso J. C., Gonzalez-Roces S., Sanchez del Río J., Rodriguez-Pérez A., Brautbar C., López-Larrea C., The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw0602 in psoriasis. Arthritis and Rheumatism 1999 42 5 1010 1016 (Pubitemid 29215013)
7. González S., Martínez-Borra J., López-Vázquez A., García-Fernández S., Torre-Alonso J. C., López-Larrea C., MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. Journal of Rheumatology 2002 29 5 973 978 (Pubitemid 34493503)
8. González S., Brautbar C., Martínez-Borra J., López-Vazquez A., Segal R., Blanco-Gelaz M. A., Enk C. D., Safriman C., López-Larrea C., Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Human Immunology 2001 62 6 632 638 2-s2.0-0034988205 10.1016/S0198-8859(01)00242-7 (Pubitemid 32506181)
9. Lee W., Reveille J. D., Davis J. C. Jr., Learch T. J., Ward M. M., Weisman M. H., Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Annals of the Rheumatic Diseases 2007 66 5 633 638 2-s2.0-34248136519 10.1136/ard.2006.060293 (Pubitemid 46707132)
10. Eder L., Thavaneswaran A., Chandran V., Gladman D. D., Gender related differences in severity of psoriatic arthritis. Arthritis and Rheumatism 2011 63 supplement 10 2486C
11. Queiro R., Sarasqueta C., Belzunegui J., Gonzalez C., Figueroa M., Torre-Alonso J. C., Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Seminars in Arthritis and Rheumatism 2002 31 6 413 418 2-s2.0-0036307929 10.1053/sarh.2002.33470 (Pubitemid 34734381)
12. Queiro R., Alperi M., Lopez A., Sarasqueta C., Riestra J. L., Ballina J., Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis. Joint Bone Spine 2008 75 5 544 547 2-s2.0-53349177185 10.1016/j.jbspin.2007.11.005
13. Gladman D. D., Brubacher B., Buskila D., Langevitz P., Farewell V. T., Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study. Clinical and Investigative Medicine 1992 15 4 371 375 2-s2.0-0026783361
14. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H., Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis and Rheumatism 2006 54 8 2665 2673 2-s2.0-33746951437 10.1002/art.21972 (Pubitemid 44205029)
15. Moll J. M. H., Wright V., Psoriatic arthritis. Seminars in Arthritis and Rheumatism 1973 3 1 55 78 2-s2.0-0015799817 10.1016/0049-0172(73)90035-8
16. Tamiya G., Ota M., Katsuyama Y., Shiina T., Oka A., Makino S., Kimura M., Inoko H., Twenty-six new polymorphic microsatellite markers around the HLA-B, -C and -E loci in the human MHC class I region. Tissue Antigens 1998 51 4, part 1 337 346 2-s2.0-0031968511
17. Zochling J., Smith E. U. R., Seronegative spondyloarthritis. Best Practice and Research: Clinical Rheumatology 2010 24 6 747 756 2-s2.0-79958861503 10.1016/j.berh.2011.02.002
18. Rudwaleit M., New approaches to diagnosis and classification of axial and peripheral spondyloarthritis. Current Opinion in Rheumatology 2010 22 4 375 380 2-s2.0-77953475973 10.1097/BOR.0b013e32833ac5cc
19. Queiro R., Sarasqueta C., Torre J. C., Tinturé T., López-Lagunas I., Spectrum of psoriatic spondyloarthropathy in a cohort of 100 Spanish patients. Annals of the Rheumatic Diseases 2002 61 9 857 858 2-s2.0-0036720364 10.1136/ard.61.9.857
20. Hüffmeier U., Reis A., Steffens M., Lascorz J., Böhm B., Lohmann J., Wendler J., Traupe H., Küster W., Wienker T. F., Burkhardt H., Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. The Journal of investigative dermatology 2006 126 4 932 935 2-s2.0-33646252483 10.1038/sj.jid.5700153
21. Gudjonsson J. E., Karason A., Runarsdottir E. H., Antonsdottir A. A., Hauksson V. B., Jónsson H. H., Gulcher J., Stefansson K., Valdimarsson H., Distinct clinical differences between HLA-Cw0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients. Journal of Investigative Dermatology 2006 126 4 740 745 2-s2.0-33645023965 10.1038/sj.jid.5700118
22. Winchester R., Minevich G., Steshenko V., Kirby B., Kane D., Greenberg D. A., Fitzgerald O., HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis and Rheumatism 2011 64 4 1134 1144 10.1002/art.33415
23. Henseler T., Christophers E., Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology 1985 13 3 450 456 2-s2.0-0021806161 (Pubitemid 15016489)
24. Queiro R., Alonso S., Alperi M., Fernández M., Sarasqueta C., Stratification by age of onset with 30 years as age limit is an effective means of identifying PSORS1-associated psoriasis in patients with psoriatic arthritis. Joint Bone Spine 2011 78 6 581 583 2-s2.0-79955078026 10.1016/j.jbspin.2011.02. 009
25. Eder L., Chandran V., Pellet F., Shanmugarajah S., Rosen C.F., Bull S.B., Gladman D.D., Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis Annals of the Rheumatic Diseases 2012 71 1 50-55. 10.1136/ard.2011.155044.